BR112021018595A2 - Cepas microbianas para inibição de vírus - Google Patents

Cepas microbianas para inibição de vírus

Info

Publication number
BR112021018595A2
BR112021018595A2 BR112021018595A BR112021018595A BR112021018595A2 BR 112021018595 A2 BR112021018595 A2 BR 112021018595A2 BR 112021018595 A BR112021018595 A BR 112021018595A BR 112021018595 A BR112021018595 A BR 112021018595A BR 112021018595 A2 BR112021018595 A2 BR 112021018595A2
Authority
BR
Brazil
Prior art keywords
strains
virus inhibition
microbial strains
microbial
compositions
Prior art date
Application number
BR112021018595A
Other languages
English (en)
Inventor
Dean SPENCER Joel
Kyle Leistikow
R King Michael
Robert Augspurger Nathan
Sona Son
Original Assignee
Microbial Discovery Group Llc
United Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microbial Discovery Group Llc, United Animal Health Inc filed Critical Microbial Discovery Group Llc
Publication of BR112021018595A2 publication Critical patent/BR112021018595A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Molecular Biology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

cepas microbianas para inibição de vírus. a presente invenção refere-se a composições compreendendo cepas microbianas para uso na inibição de vírus e métodos para as mesmas. mais particularmente, a invenção refere-se a composições de cepas de bacillus isoladas selecionadas a partir do grupo consistindo em cepas de bacillus isoladas 300, 86, 101, 235, 102, 177, a12, 54, 681, 721, cepas tendo todas as características de identificação dessas cepas e combinações das mesmas, e métodos para uso dessas cepas para inibição de vírus.
BR112021018595A 2019-03-19 2020-03-19 Cepas microbianas para inibição de vírus BR112021018595A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962820667P 2019-03-19 2019-03-19
PCT/US2020/023586 WO2020191173A1 (en) 2019-03-19 2020-03-19 Microbial strains for virus inhibition

Publications (1)

Publication Number Publication Date
BR112021018595A2 true BR112021018595A2 (pt) 2021-11-23

Family

ID=72519363

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112021018595A BR112021018595A2 (pt) 2019-03-19 2020-03-19 Cepas microbianas para inibição de vírus

Country Status (7)

Country Link
US (1) US20220143109A1 (pt)
EP (1) EP3941213A4 (pt)
CN (1) CN113825407A (pt)
BR (1) BR112021018595A2 (pt)
CA (1) CA3133990A1 (pt)
MX (1) MX2021011288A (pt)
WO (1) WO2020191173A1 (pt)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
CN101076585A (zh) * 2003-08-14 2007-11-21 生物平衡公司 细菌株系、包括该细菌株系的组合物和其益生菌用途
KR102128560B1 (ko) * 2012-04-13 2020-07-01 시에이치알. 한센 에이/에스 대장균 및 클로스트리디움 퍼프린젠스에 대한 항균 효과 및 높은 포자 형성 능력을 갖는 항생제 민감성 바실러스 균주
US10357046B2 (en) * 2014-05-13 2019-07-23 Microbial Discovery Group, Llc Direct-fed microbials and methods of their use
MX2018010428A (es) * 2016-02-29 2018-11-29 Microbial Discovery Group Llc Productos microbianos alimentados en directo.
CN106420841B (zh) * 2016-08-31 2019-10-29 东北制药集团股份有限公司 一种小檗碱和地衣芽孢杆菌组合物在制备用于预防或治疗轮状病毒感染疾病的药物中的应用
WO2019213243A1 (en) * 2018-05-01 2019-11-07 Microbial Discovery Group, Llc Microbials for feed
WO2020069255A1 (en) * 2018-09-28 2020-04-02 Microbial Discovery Group, Llc Microorganisms for plant pathogen inhibition
WO2020072578A1 (en) * 2018-10-02 2020-04-09 Microbial Discovery Group, Llc Microbials for animals

Also Published As

Publication number Publication date
MX2021011288A (es) 2021-10-13
WO2020191173A1 (en) 2020-09-24
CA3133990A1 (en) 2020-09-24
EP3941213A4 (en) 2022-12-21
CN113825407A (zh) 2021-12-21
US20220143109A1 (en) 2022-05-12
EP3941213A1 (en) 2022-01-26

Similar Documents

Publication Publication Date Title
BR112015000187A2 (pt) benzamidas substituídas com n e métodos de uso das mesmas
MX2020002727A (es) Nuevo uso para tratamiento de infecciones por clostridium difficile.
PH12018501226A1 (en) Methods for treating huntingtons disease
AR112271A1 (es) Composiciones que comprenden un inhibidor de arn polimerasa y ciclodextrina para el tratamiento de infecciones virales
CO2018000410A2 (es) Moléculas de anticuerpo que se unen a cd79
WO2019183552A3 (en) Methods and assays for modulating gene transcription by modulating condensates
MX2020009956A (es) Compuestos para el tratamiento de enfermedad de hungtinton.
MX2018009633A (es) Inhibidor de indoleamina-2,3-dioxigenasa (ido).
BR112016025009A2 (pt) anticorpos humanos para a síndrome respiratória do oriente médio - proteína de superfície
BR112018004620A2 (pt) moduladores da expressão de kras
WO2019014395A8 (en) GENERATION OF WATER-SOLUBLE CANNABINOID COMPOUNDS IN PLANT CELL SUSPENSION YEAST AND CROPS AND MATERIAL COMPOSITIONS
BR112017014230A2 (pt) endófitos de semente através de cultivares e espécies, composições associadas e métodos de uso dos mesmos
BR112021006392A2 (pt) moduladores da alfa-1 antitripsina
BR112021022624A2 (pt) Compostos para o tratamento da doença de huntington
BRPI0718688A8 (pt) Composições de baixa irritação e métodos para preparar as mesmas
EA201692303A1 (ru) Новая противоинфекционная стратегия против коинфекций, вызванных вирусом гриппа и s.aureus
BR112018003123A2 (pt) composição, enema, cepa isolada, método para tratamento e/ou prevenção de uma condição gastrointestinal, e, uso de uma composição, de um enema ou de uma ou mais de uma cepa bacteriana isolada
BR112022004976A2 (pt) Composições com base em cepas bacterianas e extratos de baga e uso do mesmo como anti-inflamatórios
WO2008054481A3 (en) Improved inactivated influenza virus compositions
ECSP21026021A (es) Moduladores de la expresión de pnpla3
BR112014000542A2 (pt) composições de peroxidase eosinofílica e métodos de uso das mesmas
CO2019010062A2 (es) Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens
BR112017007459A2 (pt) aluminossilicato
WO2018004224A3 (ko) 신규 스포리치아과 미생물 및 그의 용도
BR112022003209A2 (pt) Métodos de inibição com cepas microbianas e antibióticos